Adjuvant Holdings Co Ltd
TSE:4929
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
742
899
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
Adjuvant Holdings Co Ltd
stock under the Base Case scenario is
624.85
JPY.
Compared to the current market price of 759 JPY,
Adjuvant Holdings Co Ltd
is
Overvalued by 18%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Adjuvant Holdings Co Ltd.
| FR |
|
L'Oreal SA
PAR:OR
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
|
| JP |
|
Kao Corp
TSE:4452
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Adjuvant Holdings Co Ltd
Balance Sheet Decomposition
Adjuvant Holdings Co Ltd
| Current Assets | 3.2B |
| Cash & Short-Term Investments | 1.8B |
| Receivables | 382.7m |
| Other Current Assets | 953.5m |
| Non-Current Assets | 1.8B |
| Long-Term Investments | 298.8m |
| PP&E | 1.3B |
| Intangibles | 34.7m |
| Other Non-Current Assets | 201m |
| Current Liabilities | 491.3m |
| Accounts Payable | 127m |
| Accrued Liabilities | 84.4m |
| Other Current Liabilities | 279.8m |
| Non-Current Liabilities | 434.8m |
| Other Non-Current Liabilities | 434.8m |
Free Cash Flow Analysis
Adjuvant Holdings Co Ltd
| JPY | |
| Free Cash Flow | JPY |
Earnings Waterfall
Adjuvant Holdings Co Ltd
|
Revenue
|
3.9B
JPY
|
|
Cost of Revenue
|
-1.3B
JPY
|
|
Gross Profit
|
2.5B
JPY
|
|
Operating Expenses
|
-2.5B
JPY
|
|
Operating Income
|
49.4m
JPY
|
|
Other Expenses
|
-10.9m
JPY
|
|
Net Income
|
38.5m
JPY
|
Profitability Score
Profitability Due Diligence
Adjuvant Holdings Co Ltd's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Adjuvant Holdings Co Ltd's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Adjuvant Holdings Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Adjuvant Holdings Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Adjuvant Holdings Co Ltd
Dividends
Current shareholder yield for
Adjuvant Holdings Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Adjuvant Holdings Co Ltd
stock under the Base Case scenario is
624.85
JPY.
Compared to the current market price of 759 JPY,
Adjuvant Holdings Co Ltd
is
Overvalued by 18%.